Keeping Patients on Immunotherapy: Why Rheumatology Matters in Cancer Care – Integrative Oncology Working Group
Photo taken from Integrative Oncology Working Group/LinkedIn

Keeping Patients on Immunotherapy: Why Rheumatology Matters in Cancer Care – Integrative Oncology Working Group

Integrative Oncology Working Group shared a post on LinkedIn:

“The Integrative Oncology Working Group is honored to host Alexa Meara, MD, MS—a rheumatologist and Associate Professor in the Division of Oncology at The Ohio State University, and a pioneer in integrating rheumatology into cancer care to help patients safely remain on immunotherapy.

JOIN US – IOWG Grand Rounds (Free for Verified HCPs)

Keeping Patients on Immunotherapy: Why Rheumatology Matters in Cancer Care
Sunday, Feb 22, 2026 |  3:00 PM ET

Register (Zoom):

If you treat patients on checkpoint inhibitors, this session will be highly actionable: irAE recognition, co-management workflows, and practical strategies that can reduce unnecessary treatment holds and support safer continuation when appropriate.

Disclaimer: Views do not represent the Department of Veterans Affairs or the United States Government.”

Manoj Reddy, Founder and President at Integrative Oncology Working Group, shared this post, adding:

“Honored and looking forward to hosting Alexa Meara, MD, MS for the next Integrative Oncology Working Group Grand Rounds ‘Keeping patients on immunotherapy and why Rheumatology matters”.

This will be a highly practical session on partnering with rheumatology to recognize/manage irAEs early so more patients can stay safely on immunotherapy when appropriate.

Sunday, Feb 22, 2026 |  3:00 PM ET

Register:

Details:

Join Us!

All healthcare professionals are welcome. Please share with your oncology and primary care colleagues and teams.”

Keeping Patients on Immunotherapy: Why Rheumatology Matters in Cancer Care - Integrative Oncology Working Group

More posts about Integrative Oncology Working Group.